Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-17-008083
Filing Date
2017-07-31
Accepted
2017-07-31 16:52:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5072817_actiniumphar.htm 424B5 872527
2 GRAPHIC image001.jpg GRAPHIC 35695
3 GRAPHIC image002.jpg GRAPHIC 27209
  Complete submission text file 0001213900-17-008083.txt   960516
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194768 | Film No.: 17993569
SIC: 2834 Pharmaceutical Preparations